Advertisement

Topics

Thousands of drugs face Brexit risk, makers to duplicate testing

00:48 EST 9 Nov 2017 | Reuters

LONDON (Reuters) - Supplies of thousands of medicines are at risk of disruption if Britain leaves the European Union without a trade deal, forcing manufacturers to prepare for duplicate product testing to ensure their drugs stay on the market.

Original Article: Thousands of drugs face Brexit risk, makers to duplicate testing

NEXT ARTICLE

More From BioPortfolio on "Thousands of drugs face Brexit risk, makers to duplicate testing"

Advertisement
Quick Search
Advertisement
Advertisement